Valerian For Insomnia On Subjective And Objective Sleep Parameters A Metaanalysis Of Randomized Controlled Trials Xu Zhang Yanying Lu Feiyan Lv Yan Hu Zhentao Yao Yulong Wu Fuzhi Lian Jun Yang Xianrong Xu by Xu Zhang & Yanying Lu & Feiyan Lv & Yan Hu & Zhentao Yao & Yulong Wu & Fuzhi Lian & Jun Yang & Xianrong Xu 101007/S40675023002594 instant download after payment.

Current Sleep Medicine Reports,AbstractPurpose of Review This systematic review and meta-analysis aimed to assess the efects of valerian intervention for insomnia on both subjective and objective sleep parameters.Recent Findings Twenty-one RCTs with a total of 1433 participants were retrieved after searching on 6 electronic databases. The results indicated that, for subjective parameters, valerian may have a small to moderate efects on PSQI score (standardized mean diferences (SMD), −1.21; 95% CI [−1.92 to −0.51]), self-reported dichotomous outcome of sleep quality (risk ratio (RR) =1.37; 95% CI [1.13 to 1.68]), and self-reported sleep duration (RR=1.27; 95% CI [1.02 to 1.57]). For objective parameters, valerian only have signifcant efect on the length of non-rapid eye movement (NREM) stage 3 (SMD= 0.89; 95% CI [0.35 to 1.43]) of the patients. Heterogeneity was mainly due to varied study designs, especially in preparation, outcomes measured, duration of follow-up, and populations.Summary Valerian intervention for insomnia may improve PSQI scores, subjective dichotomous outcomes of sleep quality and duration, and time of NREM stages 3.